Suppr超能文献

肾功能障碍患者降钙素原水平的验证:4 个病例报告。

A validation of presepsin levels in kidney dysfunction patients: four case reports.

机构信息

Department of Intensive Care Medicine, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto City, Kumamoto Prefecture 860-8556 Japan.

出版信息

J Intensive Care. 2014 Dec 3;2(1):63. doi: 10.1186/s40560-014-0063-2. eCollection 2014.

Abstract

Here, we measured presepsins (PSPs) in four patients with acute kidney injury (AKI) or chronic kidney disease (CKD) and discuss the relationship between PSP and kidney dysfunction. Case 1: an 83-year-old man was admitted to the ICU to manage postoperative respiratory failure with AKI. He had undergone resection for rectal cancer and ileal conduit replacement. On day 1 in the ICU, Escherichia coli (E. coli) was isolated by urine culture. PSP level (pg/ml) on day 2 was 2,745 without elevation of other conventional biomarkers. On day 6, the patient was diagnosed with severe sepsis, and E. coli was isolated by blood culture. By then, PSP had risen to 3,977, along with elevation of other conventional biomarkers. His kidney function recovered gradually after continuous administration of hemodiafiltration; however, PSP continued to rise up to 6,051, along with high systemic inflammatory response syndrome (SIRS) and Acute Physiology and Chronic Health Evaluation (APACHE) II values. The patient expired on day 13 due to multiple organ failure. Case 2: a 78-year-old woman with CKD on hemodialysis (HD) was admitted to the ICU after cardiovascular surgery. Continuous HD was administered postoperatively, and PSP ranged from 1,473-1,870 without signs of sepsis. Temporary elevation of other conventional biomarkers was observed postoperatively. Case 3: a 74-year-old woman with CKD on HD was admitted to the ICU after neurosurgery. She underwent intermittent HD postoperatively, and PSP ranged from 1,240-1,935 without sepsis symptoms. Temporary elevation of other conventional biomarkers was observed postoperatively. Case 4: a 62-year-old man with CKD was admitted to the ICU to control gastrointestinal bleeding. PSP was 606 without signs of infection or elevation of other conventional biomarkers. In cases 2, 3, and 4, bacteria were not isolated in blood cultures. Patients' clinical prognoses were good, with low or moderate SIRS and APACHE II scores. PSP in kidney dysfunction patients will be high despite non-infectious conditions. Therefore, evaluation of PSP in kidney dysfunction patients will be difficult. Further investigation is needed to clarify the relationship between PSP and kidney dysfunction.

摘要

在这里,我们测量了四位患有急性肾损伤(AKI)或慢性肾病(CKD)的患者的前亲菌素(PSPs),并讨论了 PSP 与肾功能障碍之间的关系。

病例 1:一位 83 岁男性因 AKI 入住 ICU 以管理术后呼吸衰竭。他曾接受直肠癌切除术和回肠造口置换术。在 ICU 的第 1 天,尿液培养分离出大肠杆菌(E. coli)。第 2 天 PSP 水平(pg/ml)为 2745,其他常规生物标志物无升高。第 6 天,患者诊断为严重败血症,血培养分离出大肠杆菌。此时,PSP 已升至 3977,其他常规生物标志物也升高。持续行血液透析滤过治疗后,患者肾功能逐渐恢复;然而,PSP 持续升高至 6051,同时全身炎症反应综合征(SIRS)和急性生理学与慢性健康评估(APACHE)II 值较高。患者因多器官功能衰竭于第 13 天死亡。

病例 2:一位 78 岁女性,患有 CKD,正在进行血液透析(HD)治疗,在心血管手术后入住 ICU。术后给予连续 HD,PSP 范围为 1473-1870,无败血症迹象。术后观察到其他常规生物标志物的暂时升高。

病例 3:一位 74 岁女性,患有 CKD,正在进行 HD 治疗,在神经手术后入住 ICU。术后间歇性进行 HD,PSP 范围为 1240-1935,无败血症症状。术后观察到其他常规生物标志物的暂时升高。

病例 4:一位 62 岁男性,患有 CKD,因胃肠道出血入住 ICU。PSP 为 606,无感染迹象或其他常规生物标志物升高。在病例 2、3 和 4 中,血培养未分离出细菌。患者的临床预后良好,SIRS 和 APACHE II 评分较低或中等。尽管是非感染性疾病,肾功能障碍患者的 PSP 仍会升高。因此,对肾功能障碍患者的 PSP 进行评估将具有挑战性。需要进一步研究以阐明 PSP 与肾功能障碍之间的关系。

相似文献

1
A validation of presepsin levels in kidney dysfunction patients: four case reports.
J Intensive Care. 2014 Dec 3;2(1):63. doi: 10.1186/s40560-014-0063-2. eCollection 2014.
3
Scoring systems and outcome of chronic kidney disease patients admitted in intensive care units.
Saudi J Kidney Dis Transpl. 2018 Mar-Apr;29(2):310-317. doi: 10.4103/1319-2442.229268.
6
Prognostic value of sCD14-ST (presepsin) in cardiac surgery.
Kardiochir Torakochirurgia Pol. 2015 Mar;12(1):30-6. doi: 10.5114/kitp.2015.50565. Epub 2015 Mar 31.

引用本文的文献

1
CONGENITAL NEPHROGENIC DIABETES INSIPIDUS IN A PRETERM INFANT: CASE PRESENTATION.
Acta Endocrinol (Buchar). 2019 Jul-Sep;15(3):384-389. doi: 10.4183/aeb.2019.384.
2
Impact of initial plasma presepsin level for clinical outcome in hospitalized patients with pneumonia.
J Thorac Dis. 2019 Apr;11(4):1387-1396. doi: 10.21037/jtd.2019.03.74.
5
Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates.
PLoS One. 2015 Dec 31;10(12):e0146020. doi: 10.1371/journal.pone.0146020. eCollection 2015.

本文引用的文献

1
Presepsin as a novel sepsis biomarker.
World J Emerg Med. 2014;5(1):16-9. doi: 10.5847/wjem.j.issn.1920-8642.2014.01.002.
4
Presepsin (sCD14-ST) in emergency department: the need for adapted threshold values?
Clin Chim Acta. 2014 Jan 1;427:34-6. doi: 10.1016/j.cca.2013.09.019. Epub 2013 Sep 27.
6
Definition and classification of kidney diseases.
Am J Kidney Dis. 2013 May;61(5):686-8. doi: 10.1053/j.ajkd.2013.03.003.
7
Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study.
J Infect Chemother. 2012 Dec;18(6):891-7. doi: 10.1007/s10156-012-0435-2. Epub 2012 Jun 13.
8
Development of a point-of-care assay system for measurement of presepsin (sCD14-ST).
Clin Chim Acta. 2011 Nov 20;412(23-24):2157-61. doi: 10.1016/j.cca.2011.07.024. Epub 2011 Aug 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验